Journal Information
Vol. 16. Issue 2.
Pages 153-156 (March - April 2012)
Share
Share
Download PDF
More article options
Vol. 16. Issue 2.
Pages 153-156 (March - April 2012)
Open Access
JC virus-associated central nervous system diseases in HIV-infected patients in Brazil: Clinical presentations, associated factors with mortality and outcome
Visits
2576
Felipe Pizaa, Maria Cristina Finkb, Gilberto S. Nogueiraa, Claudio S. Pannutib, Augusto C. Penalva de Oliveirac, José Ernesto Vidala,c,
Corresponding author
josevibe@gmail.com

Corresponding author at: Rua Cristiano Viana 279/53, São Paulo, SP, 05411-000, Brazil.
a Department of Infectious Diseases, Instituto de Infectologia Emílio Ribas, São Paulo, Brazil
b Laboratory of Virology, Instituto de Medicina Tropical, Universidade de São Paulo, São Paulo, Brazil
c Department of Neurology, Instituto de Infectologia Emílio Ribas, São Paulo, Brazil
This item has received

Under a Creative Commons license
Article information
Abstract
Introduction

Several presentations of neurologic complications caused by JC virus (JCV) in human immunodeficiency virus (HIV)-infected patients have been described and need to be distinguished from the “classic” form of progressive multifocal leukoencephalopathy (PML). The objectives of this study were: 1) to describe the spectrum and frequency of presentations of JCV-associated central nervous system (CNS) diseases; 2) identify factors associated with in-hospital mortality of patients with JCV-associated CNS disease; and 3) to estimate the overall mortality of this population.

Material and methods

This was a retrospective study of HIV-infected patients admitted consecutively for JCV-associated CNS diseases in a referral teaching center in Sao Paulo, Brazil, from 2002 to 2007. All patients with laboratory confirmed JCV-associated CNS diseases were included using the following criteria: compatible clinical and radiological features associated with the presence of JCV DNA in the cerebrospinal fluid. JCV-associated CNS diseases were classified as follows: 1) classic PML; 2) inflammatory PML; and 3) JC virus granule cell neuronopathy (GCN).

Results

We included 47 cases. JCV-associated CNS diseases were classified as follows: 1) classic PML: 42 (89%); 2) inflammatory PML: three (6%); and 3) JC virus GCN: four (9%). Nosocomial pneumonia (p=0.003), previous diagnosis of HIV infection (p=0.03), and imaging showing cerebellar and/or brainstem involvement (p=0.02) were associated with in-hospital mortality. Overall mortality during hospitalization was 34%.

Conclusions

Novel presentations of JCV-associated CNS diseases were observed in our setting; nosocomial pneumonia, previous diagnosis of HIV infection, and cerebellar and/or brainstem involvement were associated with in-hospital mortality; and overall mortality was high.

Keywords:
JC virus
Leukoencephalopathy, progressive multifocal
Diagnosis
Acquired immunodeficiency syndrome
Brazil
Full text is only aviable in PDF
References
[1.]
A. D’Arminio Monforte, P. Cinque, A. Mocroft, et al.
Changing incidence of central nervous system diseases in the EuroSIDA cohort.
Ann Neurol, 55 (2004), pp. 320-328
[2.]
N. Sacktor.
The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.
J. Neurovirol, 8 (2002), pp. 115-121
[3.]
J.R. Berger.
Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: explaining the high incidence and disproportionate immunosuppressive conditions.
J Neurovirol, 9 (2003), pp. 38-41
[4.]
J.E. Vidal, A.C. Penalva de Oliveira, M.C. Fink, et al.
AIDS-related progressive multifocal leukoencephalopathy: a retrospective study in a referral center in Sao Paulo.
Brazil. Rev Inst Med Trop, 50 (2008), pp. 209-212
[5.]
J.F. Oliveira, D.B. Greco, G.C. Oliveira, et al.
Neurological disease in HIV-infected patients in the era of highly active antiretroviral treatment: a Brazilian experience.
Rev Soc Bras Med Trop, 39 (2006), pp. 146-151
[6.]
P. Cinque, I.J. Koralnik, D. Clifford.
The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: defining a consensus terminology.
J Neurovirol, 9 (2003), pp. 88-92
[7.]
I.J. Koralnik.
Progressive multifocal leukoencephalopathy revisited: has the disease outgrown its name?.
Ann Neurol, 60 (2006), pp. 162-173
[8.]
B.J. Brew, N.W. Davies, P. Cinque, et al.
Progressive multifocal leukoencephalopathy and other forms of JC virus disease.
Nat Rev Neurol, 6 (2010), pp. 667-679
[9.]
J. Gasnault, M.G. de Goer de Herve, J. Rahoiljaon, et al.
Early brainstem damage is predictive of poor survival in HIV-infected patients with progressive multifocal leukoencephalopathy.
XI Conference on Retrovirus and Opportunistic Infections,
[10.]
P. Cinque, I. Koralnik, S. Gerevini, et al.
Progressive multifocal leukoencephalopathy in HIV-1 infection.
Lancet Infect Dis, 9 (2009), pp. 625-636
[11.]
K. Tan, R. Roda, L. Ostrow, et al.
PML-IRIS in patients with HIV infection.
[12.]
I.J. Koralnik.
New insights into progressive multifocal leukoencephalopathy.
Curr Opin Neurol, 17 (2004), pp. 365-370
[13.]
P. Cinque, A.S. Bossolasco, A.M. Brambilla, et al.
The effect of highly active antiretroviral therapy-induced immune reconstitution on development and outcome of progressive multifocal leukoencephalopathy: study of 43 cases with review of the literature.
J Neurovirol, 9 (2003), pp. 1-8
[14.]
R.A. Du Pasquier, S. Corey, D.H. Margolin, et al.
Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual.
Neurology, 61 (2003), pp. 775-782
[15.]
I.J. Koralnik, C. Wuthrich, X. Dang, et al.
JC virus granule cell neuronopathy: a novel clinical syndrome distinct from progressive multifocal leukoencephalopathy.
Ann Neurol, 57 (2005), pp. 576-580
[16.]
X. Dang, I.J. Koralnik.
A granule cell neuron-associated JC virus variant has a unique deletion in the VP1 gene.
J Gen Virol, 87 (2006), pp. 2533-2537
[17.]
X. Dang, J.E. Vidal, A.C. de OIiveira, et al.
JC virus granule cell neuronopathy is associated with VP1 C terminus mutants.
J Gen Virol, 93 (2012), pp. 175-183
[18.]
C. Wuthrich, Y.M. Cheng, F.T. Joseph, et al.
Frequent infection of cerebellar granule cell neurons by polyomavirus JC in progressive multifocal leukoencephalopathy.
J Neuropathol Exp Neurol, 68 (2008), pp. 15-25
[19.]
A. Antinori, A. Cingolani, P. Lorenzini, et al.
Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA).
J Neurovirol, 9 (2003), pp. 47-53
[20.]
J. Gasnault, Y. Taoufik.
New trends in progressive multifocal leukoencephalopathy.
Rev Neurol (Paris), 162 (2006), pp. 43-56
[21.]
A. Marzocchetti, T. Tompkins, D.B. Clifford, et al.
Determinants of survival in progressive multifocal leukoencephalopathy.
Neurology, 73 (2009), pp. 1551-1558
[22.]
F.N. Engsig, A.B.E. Hartsen, L.H. Omland, et al.
Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study.
Clin Infect Dis, 199 (2009), pp. 77-83
[23.]
M.A. Lima, F. Bernal-Cano, D.B. Clifford, et al.
Clinical outcome of long-term survivors of progressive multifocal leukoencephalopathy.
J Neurol Neurosurg Psychiatry, 81 (2010), pp. 1288-1291
[24.]
J.E. Vidal, A.V. Hernandez, A.C. Penalva de Oliveira, et al.
Cerebral toxoplasmosis in HIV-positive patients in Brazil: clinical features and predictors of treatment response in the HAART era.
AIDS Patient Care and STDS, 19 (2005), pp. 626-634
Copyright © 2012. Elsevier Editora Ltda.. All rights reserved
The Brazilian Journal of Infectious Diseases
Article options
Tools